Sarepta Therapeutics, Inc. (SRPT) › Shareholders' EquitySarepta Therapeutics, Inc. (SRPT) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: -$2.82M2011: $31.02M2012: $123.68M2013: $247.19M2014: $247.65M2015: $190.35M2016: $336.69M2017: $789.22M2018: $1.03B2019: $818.19M2020: $761.76M2021: $928.01M2022: $384.95M2023: $859.34M2024: $1.53B2025: $1.14B$1.14B2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$1.14B-25.3%2024$1.53B+77.8%2023$859.34M+123.2%2022$384.95M-58.5%2021$928.01M+21.8%2020$761.76M-6.9%2019$818.19M-20.7%2018$1.03B+30.8%2017$789.22M+134.4%2016$336.69M+76.9%2015$190.35M-23.1%2014$247.65M+0.2%2013$247.19M+99.9%2012$123.68M+298.7%2011$31.02M+1201.1%2010-$2.82M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share